Correction: Cytokine Receptor-Like Factor 1 (CRLF1) Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway

by Brendan D. Looyenga, James Resau, Jeffrey P. MacKeigan
Published 2014-01-01

Correction: Cytokine Receptor-Like Factor 1 () Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway.

by Brendan D. Looyenga, James Resau, Jeffrey P. MacKeigan
Published 2014-01-01

Cytokine receptor-like factor 1 (CRLF1) protects against 6-hydroxydopamine toxicity independent of the gp130/JAK signaling pathway.

by Brendan D Looyenga, James Resau, Jeffrey P MacKeigan
Published 2013-01-01

Met kinetic signature derived from the response to HGF/SF in a cellular model predicts breast cancer patient survival.

by Gideon Y Stein, Nir Yosef, Hadar Reichman, Judith Horev, Adi Laser-Azogui, Angelique Berens, James Resau, Eytan Ruppin, Roded Sharan, Ilan Tsarfaty
Published 2012-01-01